Home › Funds › Polar Asset Management Partners Inc. › XERS

Polar Asset Management Partners Inc. position in XERS

XERIS BIOPHARMA HOLDINGS INC · Health Care

Polar Asset Management Partners Inc. reported holding 10,500,000 shares of XERS (XERIS BIOPHARMA HOLDINGS INC) in its Q2 2026 13F filing — a position valued at US$28.8M, representing 0.57% of its reported portfolio and ranking #32 among its reported holdings. Polar Asset Management Partners Inc. has disclosed XERS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)10.50M sh
Reported value held$28.80M
Portfolio Weight0.57%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Polar Asset Management Partners Inc.'s XERS position evolved

Polar Asset Management Partners Inc. first disclosed a stake in XERS in Q3 2025 at 10,500,000 shares (US$28.7M). The position peaked in Q2 2026 at 10,500,000 shares, worth US$28.8M. Across 4 filings, Polar Asset Management Partners Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 10,500,000 shares valued at US$28.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 10.50M $28.72M New
Q4 2025 10.50M $27.95M Hold
Q1 2026 10.50M $21.49M Hold
Q2 2026 10.50M $28.80M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XERS and 13F data

XERS (XERIS BIOPHARMA HOLDINGS INC) is a Health Care company. 52 other funds we track also report a position in XERS — the largest reported positions include CAPSTONE INVESTMENT ADVISORS, LLC (US$62.6M), Rosalind Advisors, Inc. (US$23.0M), Parkman Healthcare Partners LLC (US$14.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XERS

All XERS fund holders →

FAQ

How long has Polar Asset Management Partners Inc. held XERS?

Polar Asset Management Partners Inc. has disclosed XERS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Polar Asset Management Partners Inc.'s current position in XERS?

As of Q2 2026, Polar Asset Management Partners Inc. holds 10.50M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), valued at $28.80M, representing 0.57% of its reported portfolio and ranking #32.

Has Polar Asset Management Partners Inc. been buying or selling XERS?

In the latest 13F filing (Q2 2026), Polar Asset Management Partners Inc. held unchanged its position in XERS. The position peaked in Q2 2026 at 10.50M shares.

Which other funds hold XERS?

Other major institutional holders of XERS include CAPSTONE INVESTMENT ADVISORS, LLC, Rosalind Advisors, Inc., Parkman Healthcare Partners LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.